Soyasaponin I alleviates hypertensive intracerebral hemorrhage by inhibiting the renin–angiotensin–aldosterone system

References

• Diener HC, Hankey GJ. Primary and secondary prevention of Ischemic stroke and cerebral hemorrhage: JACC focus seminar. J Am Coll Cardiol. 2020 Apr 21;75(15):1804–10. doi:10.1016/j.jacc.2019.12.072.
   PubMed Web of Science ®Google Scholar
• Zille M, Farr TD, Keep RF, Römer C, Xi G, Boltze J. Novel targets, treatments, and advanced models for intracerebral haemorrhage. EBioMedicine. 2022 Feb;76:103880. doi:10.1016/j.ebiom.2022.103880.
   PubMed Web of Science ®Google Scholar
• Walsh KB, Woo D, Sekar P, Osborne J, Moomaw CJ, Langefeld CD, Adeoye O. Untreated hypertension: a powerful risk factor for lobar and nonlobar intracerebral hemorrhage in whites, blacks, and hispanics. Circulation. 2016 Nov 8;134(19):1444–52. doi:10.1161/CIRCULATIONAHA.116.024073.
   PubMed Web of Science ®Google Scholar
• Schrag M, Kirshner H. Management of intracerebral hemorrhage: JACC focus seminar. J Am Coll Cardiol. 2020 Apr 21;75(15):1819–31. doi:10.1016/j.jacc.2019.10.066.
   PubMed Web of Science ®Google Scholar
• Paz Ocaranza M, Riquelme JA, Garcia L, Jalil JE, Chiong M, Santos RAS, Lavandero S. Counter-regulatory renin-angiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020 Feb;17(2):116–29. doi:10.1038/s41569-019-0244-8.
   PubMed Web of Science ®Google Scholar
• Li L, Zuurbier SM, Kuker W, Warlow CP, Rothwell PM. Blood pressure control and recurrent stroke after intracerebral hemorrhage in 2002 to 2018 versus 1981 to 1986: population-based study. Stroke. 2021 Oct;52(10):3243–48. doi:10.1161/STROKEAHA.121.034432.
   PubMed Web of Science ®Google Scholar
• Vicente-Gutierrez C, Bonora N, Bobo-Jimenez V, Jimenez-Blasco D, Lopez-Fabuel I, Fernandez E, Josephine C, Bonvento G, Enriquez JA, Almeida A, et al. Astrocytic mitochondrial ROS modulate brain metabolism and mouse behaviour. Nat Metab. 2019 Feb;1(2):201–11. doi:10.1038/s42255-018-0031-6.
   PubMedGoogle Scholar
• Zhang S, Lachance BB, Mattson MP, Jia X. Glucose metabolic crosstalk and regulation in brain function and diseases. Prog Neurobiol. 2021 Sep;204:102089. doi:10.1016/j.pneurobio.2021.102089.
   PubMed Web of Science ®Google Scholar
• Caron A, Lee S, Elmquist JK, Gautron L. Leptin and brain-adipose crosstalks. Nat Rev Neurosci. 2018 Feb 16;19(3):153–65. doi:10.1038/nrn.2018.7.
   PubMed Web of Science ®Google Scholar
• Kazak L, Cohen P. Creatine metabolism: energy homeostasis, immunity and cancer biology. Nat Rev Endocrinol. 2020 Aug;16(8):421–36. doi:10.1038/s41574-020-0365-5.
   PubMed Web of Science ®Google Scholar
• Qureshi MI, Vorkas PA, Coupland AP, Jenkins IH, Holmes E, Davies AH. Lessons from metabonomics on the neurobiology of stroke. Neuroscientist. 2017 Aug;23(4):374–82. doi:10.1177/1073858416673327.
   PubMed Web of Science ®Google Scholar
• Montaner J, Ramiro L, Simats A, Tiedt S, Makris K, Jickling GC, Debette S, Sanchez J-C, Bustamante A. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke. Nat Rev Neurol. 2020 May;16(5):247–64. doi:10.1038/s41582-020-0350-6.
   PubMed Web of Science ®Google Scholar
• Profaci CP, Munji RN, Pulido RS, Daneman R. The blood-brain barrier in health and disease: important unanswered questions. J Exp Med. 2020 Apr 6;217(4). doi:10.1084/jem.20190062.
   PubMed Web of Science ®Google Scholar
• Magid-Bernstein J, Girard R, Polster S, Srinath A, Romanos S, Awad IA, Sansing LH. Cerebral hemorrhage: pathophysiology, treatment, and future directions. Circ Res. 2022 Apr 15;130(8):1204–29. doi:10.1161/CIRCRESAHA.121.319949.
   PubMed Web of Science ®Google Scholar
• Bai Q, Sheng Z, Liu Y, Zhang R, Yong VW, Xue M. Intracerebral haemorrhage: from clinical settings to animal models. Stroke Vasc Neurol. 2020 Dec;5(4):388–95. doi:10.1136/svn-2020-000334.
   PubMedGoogle Scholar
• Veltkamp R, Purrucker J. Management of spontaneous intracerebral hemorrhage. Curr Neurol Neurosci Rep. 2017 Sep 8;17(10):80. doi:10.1007/s11910-017-0783-5.
   PubMed Web of Science ®Google Scholar
• Patel S, Rauf A, Khan H, Abu-Izneid T. Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies. Biomed Pharmacother. 2017 Oct;94:317–25. doi:10.1016/j.biopha.2017.07.091.
   PubMed Web of Science ®Google Scholar
• Mascolo A, Sessa M, Scavone C, De Angelis A, Vitale C, Berrino L, Rossi F, Rosano G, Capuano A. New and old roles of the peripheral and brain renin-angiotensin-aldosterone system (RAAS): focus on cardiovascular and neurological diseases. Int J Cardiol. 2017 Jan 15;227:734–42. doi:10.1016/j.ijcard.2016.10.069.
   PubMed Web of Science ®Google Scholar
• Rinschen MM, Ivanisevic J, Giera M, Siuzdak G. Identification of bioactive metabolites using activity metabolomics. Nat Rev Mol Cell Biol. 2019 Jun;20(6):353–67. doi:10.1038/s41580-019-0108-4.
   PubMed Web of Science ®Google Scholar
• Schmidt DR, Patel R, Kirsch DG, Lewis CA, Vander Heiden MG, Locasale JW. Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J Clin. 2021 Jul;71(4):333–58. doi:10.3322/caac.21670.
   PubMed Web of Science ®Google Scholar
• Marklund M, Wu JHY, Imamura F, Del Gobbo LC, Fretts A, de Goede J, Shi P, Tintle N, Wennberg M, Aslibekyan S, et al. Biomarkers of dietary Omega-6 fatty acids and incident cardiovascular disease and mortality. Circulation. 2019 May 21;139(21):2422–36. doi:10.1161/CIRCULATIONAHA.118.038908.
   PubMed Web of Science ®Google Scholar
• Sun D, Tiedt S, Yu B, Jian X, Gottesman RF, Mosley TH, Boerwinkle E, Dichgans M, Fornage M. A prospective study of serum metabolites and risk of ischemic stroke. Neurology. 2019 Apr 16;92(16):e1890–e1898. doi:10.1212/WNL.0000000000007279.
   PubMed Web of Science ®Google Scholar
• Kimberly WT, Wang Y, Pham L, Furie KL, Gerszten RE. Metabolite profiling identifies a branched chain amino acid signature in acute cardioembolic stroke. Stroke. 2013 May;44(5):1389–95. doi:10.1161/STROKEAHA.111.000397.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Y, Liang Y, Sun P, Wu X, Song J, Sun X, Hong M, Gao P, Deng D, et al. Distinguishing intracerebral hemorrhage from acute cerebral infarction through metabolomics. Rev Invest Clin. 2017 Nov-Dec;69(6):319–28. doi:10.24875/RIC.17002348.
   PubMedGoogle Scholar
• Singh B, Singh JP, Singh N, Kaur A. Saponins in pulses and their health promoting activities: a review. Food Chem. 2017 Oct;15(233):540–49. doi:10.1016/j.foodchem.2017.04.161.
   Google Scholar
• Zhang W, Popovich DG. Group B oleanane triterpenoid extract containing soyasaponins I and III from soy flour induces apoptosis in Hep-G2 cells. J Agric Food Chem. 2010 May 12;58(9):5315–19. doi:10.1021/jf9037979.
   PubMed Web of Science ®Google Scholar
• Hsu CC, Lin TW, Chang WW, Wu C-Y, Lo W-H, Wang P-H, Tsai Y-C. Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids. Gynecol Oncol. 2005 Feb;96(2):415–22. doi:10.1016/j.ygyno.2004.10.010.
   PubMed Web of Science ®Google Scholar
• Chang WW, Yu CY, Lin TW, Wang P-H, Tsai Y-C. Soyasaponin I decreases the expression of alpha2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells. Biochem Biophys Res Commun. 2006 Mar 10;341(2):614–19. doi:10.1016/j.bbrc.2005.12.216.
   PubMed Web of Science ®Google Scholar
• Sung PL, Wen KC, Horng HC, Chang C-M, Chen Y-J, Lee W-L, Wang P-H. The role of alpha2,3-linked sialylation on clear cell type epithelial ovarian cancer. Taiwan J Obstet Gynecol. 2018 Apr;57(2):255–63. doi:10.1016/j.tjog.2018.02.015.
   PubMed Web of Science ®Google Scholar
• Xia X, Lin Q, Zhao N, Zeng J, Yang J, Liu Z, Huang R. Anti-colon cancer activity of dietary phytochemical Soyasaponin I and the induction of metabolic shifts in HCT116. Molecules. 2022 Jul 8;27(14):4382. doi:10.3390/molecules27144382.
   PubMed Web of Science ®Google Scholar
• Lee IA, Park YJ, Yeo HK, Han MJ, Kim D-H. Soyasaponin I attenuates TNBS-induced colitis in mice by inhibiting NF-kappaB pathway. J Agric Food Chem. 2010 Oct 27;58(20):10929–34. doi:10.1021/jf102296y.
   PubMed Web of Science ®Google Scholar
• Zha L, Chen J, Sun S, Mao L, Chu X, Deng H, Cai J, Li X, Liu Z, Cao W, et al. Soyasaponins can blunt inflammation by inhibiting the reactive oxygen species-mediated activation of PI3K/Akt/NF-kB pathway. PLoS One. 2014;9(9):e107655. doi:10.1371/journal.pone.0107655.
   PubMed Web of Science ®Google Scholar
• Hong SW, Heo H, Yang JH, Han M, Kim D-H, Kwon YK. Soyasaponin I improved neuroprotection and regeneration in memory deficient model rats. PLoS One. 2013;8(12):e81556. doi:10.1371/journal.pone.0081556.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Hori K, Shinbo M, Hiwatashi K, GOTOH T, Yamada S. Isolation of human renin inhibitor from soybean: soyasaponin I is the novel human renin inhibitor in soybean. Biosci Biotechnol Biochem. 2008 Dec;72(12):3232–36. doi:10.1271/bbb.80495.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Hori K, Hokari M, Gotoh T, Sugiyama T. Inhibition of human renin activity by saponins. Biomed Res. 2010 Apr;31(2):155–59. doi:10.2220/biomedres.31.155.
   PubMed Web of Science ®Google Scholar
• Tavassoli Z, Taghdir M, Ranjbar B. Renin inhibition by soyasaponin I: a potent native anti-hypertensive compound. J Biomol Struct Dyn. 2018 Jan;36(1):166–76. doi:10.1080/07391102.2016.1270855.
   PubMed Web of Science ®Google Scholar